IBDEI1KI ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25056,1,3,0)
 ;;=3^Family Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,25056,1,4,0)
 ;;=4^Z80.51
 ;;^UTILITY(U,$J,358.3,25056,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,25057,0)
 ;;=Z83.41^^107^1212^36
 ;;^UTILITY(U,$J,358.3,25057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25057,1,3,0)
 ;;=3^Family Hx of Mult Endocrine Neoplasia Syndrome
 ;;^UTILITY(U,$J,358.3,25057,1,4,0)
 ;;=4^Z83.41
 ;;^UTILITY(U,$J,358.3,25057,2)
 ;;=^5063380
 ;;^UTILITY(U,$J,358.3,25058,0)
 ;;=Z81.8^^107^1212^43
 ;;^UTILITY(U,$J,358.3,25058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25058,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence,Psychoactive
 ;;^UTILITY(U,$J,358.3,25058,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,25058,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,25059,0)
 ;;=Z81.4^^107^1212^44
 ;;^UTILITY(U,$J,358.3,25059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25059,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence NEC
 ;;^UTILITY(U,$J,358.3,25059,1,4,0)
 ;;=4^Z81.4
 ;;^UTILITY(U,$J,358.3,25059,2)
 ;;=^5063362
 ;;^UTILITY(U,$J,358.3,25060,0)
 ;;=Z98.0^^107^1212^55
 ;;^UTILITY(U,$J,358.3,25060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25060,1,3,0)
 ;;=3^Intestinal Bypass/Anastomosis Status
 ;;^UTILITY(U,$J,358.3,25060,1,4,0)
 ;;=4^Z98.0
 ;;^UTILITY(U,$J,358.3,25060,2)
 ;;=^5063733
 ;;^UTILITY(U,$J,358.3,25061,0)
 ;;=Z91.128^^107^1212^54
 ;;^UTILITY(U,$J,358.3,25061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25061,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Other Reasons
 ;;^UTILITY(U,$J,358.3,25061,1,4,0)
 ;;=4^Z91.128
 ;;^UTILITY(U,$J,358.3,25061,2)
 ;;=^5063613
 ;;^UTILITY(U,$J,358.3,25062,0)
 ;;=Z77.120^^107^1212^60
 ;;^UTILITY(U,$J,358.3,25062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25062,1,3,0)
 ;;=3^Mold (Toxic) Contact/Exposure
 ;;^UTILITY(U,$J,358.3,25062,1,4,0)
 ;;=4^Z77.120
 ;;^UTILITY(U,$J,358.3,25062,2)
 ;;=^5063318
 ;;^UTILITY(U,$J,358.3,25063,0)
 ;;=Z86.74^^107^1212^104
 ;;^UTILITY(U,$J,358.3,25063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25063,1,3,0)
 ;;=3^Personal Hx of Sudden Cardiac Arrest 
 ;;^UTILITY(U,$J,358.3,25063,1,4,0)
 ;;=4^Z86.74
 ;;^UTILITY(U,$J,358.3,25063,2)
 ;;=^5063478
 ;;^UTILITY(U,$J,358.3,25064,0)
 ;;=Z86.718^^107^1212^111
 ;;^UTILITY(U,$J,358.3,25064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25064,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis/Embolism (DVT)
 ;;^UTILITY(U,$J,358.3,25064,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,25064,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,25065,0)
 ;;=Z96.1^^107^1212^133
 ;;^UTILITY(U,$J,358.3,25065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25065,1,3,0)
 ;;=3^Presence of Intraocular Lens
 ;;^UTILITY(U,$J,358.3,25065,1,4,0)
 ;;=4^Z96.1
 ;;^UTILITY(U,$J,358.3,25065,2)
 ;;=^5063682
 ;;^UTILITY(U,$J,358.3,25066,0)
 ;;=Z96.612^^107^1212^138
 ;;^UTILITY(U,$J,358.3,25066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25066,1,3,0)
 ;;=3^Presence of Left Artificial Shoulder Joint
 ;;^UTILITY(U,$J,358.3,25066,1,4,0)
 ;;=4^Z96.612
 ;;^UTILITY(U,$J,358.3,25066,2)
 ;;=^5063693
 ;;^UTILITY(U,$J,358.3,25067,0)
 ;;=Z96.611^^107^1212^143
 ;;^UTILITY(U,$J,358.3,25067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25067,1,3,0)
 ;;=3^Presence of Right Artificial Shoulder Joint
 ;;^UTILITY(U,$J,358.3,25067,1,4,0)
 ;;=4^Z96.611
 ;;^UTILITY(U,$J,358.3,25067,2)
 ;;=^5063692
